Cytori Therapeutics Inc. (CYTX) financial statements (2021 and earlier)

Company profile

Business Address 4200 MARATHON BLVD.
AUSTIN, TX 78756
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments818510131423
Cash and cash equivalents818510131415
Short-term investments      8
Restricted cash and investments 0010  
Receivables 100111
Inventory, net of allowances, customer advances and progress billings 033445
Inventory 033445
Prepaid expense      2
Other current assets1111121
Other undisclosed current assets      (10)
Total current assets:9201015192122
Noncurrent Assets
Operating lease, right-of-use asset11
Property, plant and equipment2233122
Intangible assets, net (including goodwill)001011121313
Goodwill0044444
Intangible assets, net (excluding goodwill)0 67899
Restricted cash and investments     00
Other noncurrent assets0023222
Total noncurrent assets:331417161617
TOTAL ASSETS:12232432353839
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2335676
Accounts payable1011111
Accrued liabilities0112232
Employee-related liabilities1111121
Other undisclosed accounts payable and accrued liabilities0111111
Debt61114147 7
Liabilities of business transferred under contractual arrangement      3
Other undisclosed current liabilities0    20
Total current liabilities:914181813816
Noncurrent Liabilities
Long-term debt and lease obligation, including:11  111718
Finance lease, liability 0
Operating lease, liability11
Other undisclosed long-term debt and lease obligation    111718
Liabilities, other than long-term debt 000001
Deferred revenue and credits0001
Contract with customer, liability0
Deferred rent credit  0
Other liabilities 0     
Other undisclosed noncurrent liabilities(1)7100010
Total noncurrent liabilities:1810111729
Total liabilities:9221919242544
Stockholders' equity
Stockholders' equity attributable to parent315131112(6)
Common stock0000000
Additional paid in capital437426418413389368332
Accumulated other comprehensive income  11111
Accumulated deficit(434)(425)(414)(402)(379)(357)(338)
Total stockholders' equity:315131112(6)
TOTAL LIABILITIES AND EQUITY:12232432353839

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues  43555
Revenue, net  55
Cost of revenue
(Cost of Goods and Services Sold)
(0) (1)(1)(3)(3)(3)
Other undisclosed gross profit   (1)   
Gross profit:(0) 30222
Operating expenses(10)(11)(17)(25)(28)(24)(37)
Other undisclosed operating income0724773
Operating loss:(10)(4)(13)(21)(20)(15)(32)
Nonoperating income (expense)100(2)(2)(3)(5)
Investment income, nonoperating0000000
Other nonoperating income (expense)  0000(1)
Interest and debt expense(1)(2)(2)(2)(3)(3)(4)
Loss from continuing operations before income taxes:(9)(5)(15)(25)(25)(22)(42)
Other undisclosed income from continuing operations12     
Loss from continuing operations:(8)(3)(15)(25)(25)(22)(42)
Loss from discontinued operations (8)     
Net loss:(8)(11)(15)(25)(25)(22)(42)
Other undisclosed net income attributable to parent  22334
Net loss attributable to parent:(8)(11)(13)(23)(22)(19)(37)
Preferred stock dividends and other adjustments (1)(2)(4) (1)(1)
Net loss available to common stockholders, diluted:(8)(11)(15)(27)(22)(19)(39)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(8)(11)(15)(25)(25)(22)(42)
Other comprehensive income     00
Comprehensive loss:(8)(11)(15)(25)(25)(22)(41)
Other undisclosed comprehensive income, net of tax, attributable to parent  22334
Comprehensive loss, net of tax, attributable to parent:(8)(11)(13)(23)(22)(18)(37)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: